首页> 外文OA文献 >Impact of Treatment With Biologic Agents on the Use of Mechanical Devices Among Rheumatoid Arthritis Patients in a Large US Patient Registry

【2h】

Impact of Treatment With Biologic Agents on the Use of Mechanical Devices Among Rheumatoid Arthritis Patients in a Large US Patient Registry

机译：生物制剂治疗对大型患者注册表中类风湿性关节炎患者机械装置的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Vibeke Strand; Jeffrey D. Greenberg; Jenny Griffith; Yanjun Bao; Katherine C. Saunders; Vishvas Garg; Guo Li; Arijit Ganguli;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: Results from the Swiss SCQM registry [J] . ZuffereyP., DudlerJ., SchererA., Joint, bone, spine : . 2013,第2期

机译：开始使用生物制剂和治疗一年后，类风湿关节炎患者的疾病活动：瑞士SCQM注册中心的结果
2. Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry. [J] . Hetland ML, Lindegaard HM, Hansen A, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2008,第7期

机译：用生物制剂治疗的类风湿关节炎患者的处方改变会影响治疗反应和治疗依从性吗？全国丹麦DANBIO注册中心的结果。
3. Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE) [J] . G. Carlino, M. Fornaro, L. Santo, Reumatismo . 2019,第1期

机译：在使用第一种生物药物治疗后，隐匿性HBV感染可能对类风湿关节炎患者的药物生存产生负面影响。来自生物普利亚注册局（BIOPURE）的评估
4. Antiresorptive effect of denosumab in the treatment of osteoporosis in patients with rheumatoid arthritis [C] . M. A. Korolev, N. E. Banshchikova, E. A. Letjagina, 2017 International Multi-Conference on Engineering, Computer and Information Sciences . 2017

机译：地诺单抗对类风湿关节炎骨质疏松症的抗吸收作用
5. Impact of Ultrasonography on Use of Biologics in Patients with Rheumatoid Arthritis [D] . Atzinger, Christopher B. 2018

机译：超声检查对类风湿关节炎患者使用生物制剂的影响
6. Monitoring Drug and Antidrug Levels: A Rational Approach in Rheumatoid Arthritis Patients Treated with Biologic Agents Who Experience Inadequate Response While Being on a Stable Biologic Treatment [O] . Diana Mazilu, Daniela Opriş, Cecilia Gainaru, -1

机译：监测药物和抗药物水平：类风湿性关节炎患者的合理方法是在接受稳定的生物治疗时遇到反应不足的生物制剂
7. Results of cross-sectional epidemiologic study on determination of recombinant biological agents requirement for treatment of patients with rheumatoid arthritis in real-life clinical practice. Report 1. Demographic, social, clinicaland laboratory characteristics of Russian patients with rheumatoid arthritis [O] . S F Erdes, O M Folomeeva, E A Galishko, 2009

机译：真生临床实践中类风湿性关节炎患者治疗重组生物学试剂的横截面流行病学研究的结果。报告1.俄罗斯类风湿性关节炎患者的人口，社会，临床实验室特征

Impact of Treatment With Biologic Agents on the Use of Mechanical Devices Among Rheumatoid Arthritis Patients in a Large US Patient Registry

著录项

引文网络

相似文献

相关主题

期刊订阅